California Research Med Group is categorized under Medical Labs in Fullerton, CA and active since 2001.
California Research Med Group was established in 2001, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Medical Labs business, which does work in the B2C market, and is classified as a Medical Labs, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Monta Pearle, Director at the company’s single location by writing to 301 West Bastanchury Road # 220, Fullerton, California CA 92835 or by phoning (714) 992-2555. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | California Research Med Group |
Contact Person: | Monta Pearle, Director |
Address: | 301 West Bastanchury Road # 220, Fullerton, California 92835 |
Phone Number: | (714) 992-2555 |
Annual Revenue (USD): | $1.000.000 to $2.499.999 |
Founded: | 2001 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Medical Labs |
SIC Code: | 8071 |
NAICS Code: | 6211110 |
Share This Business: |
California Research Med Group was started in 2001 to provide professional Medical Labs under the SIC code 8071 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Monta Pearle, Director for inquiries that concern California Research Med Group by calling the company number (714) 992-2555, as your correspondence is most welcome. Additionally, the physical location of the single location of California Research Med Group can be found at the coordinates 33.895809,-117.92734 as well as the street address 301 West Bastanchury Road # 220 in Fullerton, California 92835.
For its online presence, you may visit California Research Med Group’s website at and engage with its social media outlets through on Twitter and on Facebook.